By Jeff Kronenfeld Could 18-MC, a synthetic derivative of Ibogaine, make treatment safer without the psychedelic trip? With COVID-19 still spreading, mutating and killing, it’s easy to forget the other health crises ravaging the country. One of the most concerning of these is drug overdose deaths, with opioids representing a large share of such casualties. From …
Continue reading “Comparing 18-MC vs. Ibogaine for the Treatment of Substance Use Disorder”
The post Comparing 18-MC vs. Ibogaine for the Treatment of Substance Use Disorder appeared first on Psychedelics Today.
